Real-time enrollment status for this metastatic pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:38 PM UTC
| NCT Number | NCT07490301 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 900 participants |
| Active Locations | 9 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07490301 is currently recruiting participants. This phase2 study for metastatic pancreatic ductal adenocarcinoma is actively seeking new participants at 9 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07490301 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07490301 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.